WebMD’s Post

🌟 Proud to follow John Whyte, an influential voice in healthcare IT! 📊 It's always inspiring to connect with someone sharing the same name and passion for innovation in healthcare. Check out this list of 30 healthcare IT influencers worth following. Let's keep pushing the boundaries of what's possible in healthcare! #HealthcareIT #Innovation #Leadership #HealthTech #Inspiration 🚀💼

🌟 Healthcare IT Influencers to Follow in 2024! 🌟 CDW Healthcare released a list of the top 30 change-makers and innovators in healthcare IT, from AI pioneers to equity advocates. These leaders are shaping the future of healthcare, driving improvements in patient care and industry trends. https://bit.ly/3VW1XR9 #Healthcare #HealthIT

🤔How to find hidden doctor influencers on social media? 👉First answer 👇 👉What is their subject area in medicine they can influence? ✅Is it a therapeutic area? ✅A procedure or class of treatment? ✅An aspect of care delivery or policy? 🤚Another important part for DOL campaigns, don’t miss this. 👉Medical campaigns with just one or two Digital Doctors Influencers don’t work. 👉Influence doesn’t happen in a vacuum. 👉It is important to look at clusters of DOL’s influence and their ecosystem of influence. 👉Further it is important to map geographic influence of the DOL. ✅This exercise includes mapping physicians’ follower network.  ✅Who engages with them when they publish? 👉With social media, pharma marketers can partner with DOLs who can help to create positive SOV around the brand molecules.  👉This can be via scientific content, research papers, abstracts, or how the treatment helps. 👉Do follow me Moses Gomes, for more tips on how to up your game to build your brand on digital, click on the 🔔 icon 👉 And if you need help with doctor opinion leaders in your specialty, send me a DM. #digitalhealth #PatientCentric #DigitalWellness #PharmaMarketing

Medical Science Liaison Society recently hosted a series of insightful webinars where medical affairs leaders delved into key industry topics. From virtual expert engagement challenges to the impact of digital influencers, these discussions covered a wide array of relevant themes. Moreover, through short surveys and germane questions, the Society uncovered high-level patterns and trends in areas such as cross-functional collaboration, insight gathering, strategic planning, and precision medicine. Stay tuned for the release of our comprehensive review paper to explore these emergent insights further. #MedicalAffairs #HealthcareIndustry #Insights #PrecisionMedicine

😎 10 Healthcare Influencers Mastering Their Personal Brands We know your day is hectic, and the world of social media can feel overwhelming at times. But we also recognize the value of building a powerful personal brand to elevate your professional journey. As highlighted by Kevin Pho, M.D. the importance of business, branding, and marketing knowledge for medical practitioners is often neglected in formal education. To spark some inspiration, we've curated a list of 10 exceptional operating room professionals who are rocking their personal brands Check out the complete list here : https://lnkd.in/eBNUu8YW Betsy Grunch, MD, FAANS, FACS Aditaya Kumar Lola Chambless Ali A. Baaj MD Rebecca Love RN, MSN, FIEL Herrick Siegel, MD Donna Wilk Cardillo RN, MA, CSP, FAAN (she/her) Mark McLaughlin, M.D. Cory Calendine, MD Brian Hoeflinger Thoughts? Who are your favorite healthcare influencers crushing it on social? Drop their handles below! 👇

If you believe #GLP-1 agonists for #obesity treatment are just another class of #pharma products, you’re wrong. This market is unfolding like nothing we’ve seen in healthcare before. That means the strategies we’ve traditionally used to approach market access, brand marketing, corporate affairs and brand communications, medical affairs and everything else we do in #healthcare may not apply here.    Real Chemistry’s first market-view report, titled “GLP-1 Agonists: Signals of a New Era,” underscores this reality… 💡 There’s a new “GLP-1 influencer” in town with online behaviors, content creation momentum and monetization approaches that mirror what has been seen with the beauty and fashion influencer community, rather than with healthcare influencers. This new phenomenon is putting additional strain on an already complex patient-healthcare provider relationship and creating pressure for marketing and communication teams to create new ways to engage, educate and activate.   💡 Growing consumer-led, online communities are joining forces to navigate and advise others on managing market impacts, such as shortages and access. As a result, these communities are circumventing the traditional ecosystem, creating gaps in real-world data visibility and adversely impacting the healthcare provider-patient relationship.   💡 Currently, there are 119 active GLP-1 agonist clinical trials, with 53 in Phases 3 or 4. These trials cover more than 60 potential new disease states for GLP-1 treatment. The potential market entry of new drugs in five to 10 years means that organizations that are exploring launching new products will need stronger commercial readiness strategies to optimize their potential position with investors.   Leaders, brand planning season is upon us. How are you preparing for the impacts this market will have on your #business? Send me a message or comment here.    IRIS has the insights into what's happening now and the forces that could shape what's coming next: https://bit.ly/3wp8D0d. It’s time to see. #glp1s #healthcareinsights #marketintelligence #research #brandstrategy #planning #realchemistry

A cultural shift is underway in health and trust. Who is impacting your health decisions? Is it your doctor, brands or relatable influencers? If you’re heading to SXSW, join us to explore this transformation with Megan Murray Consulting Partner at AnalogFolk Group (AFG), Lauren Felix (MacPherson) Director, Brand Building & Marketing Excellence at Bayer | Consumer Health NA and renowned parenting influencer La Guardia Cross. Our session will explore how influencers balance being a source of perspective for people without overpromising their qualifications and will unravel the intricate interplay between trust, cultural shifts, and the future trajectory of health and well-being brands. Add it to your SXSW schedule below👇 #SXSW #TrustShift #BrandTrust #HealthWellness #InfluencerResponsibility #MarketingInnovation #DigitalInnovation

A cultural shift is underway in health and trust. Who is impacting your health decisions? Is it your doctor, brands or relatable influencers? If you’re heading to SXSW, join us to explore this transformation with Megan Murray Consulting Partner at AnalogFolk Group (AFG), Lauren Felix (MacPherson) Director, Brand Building & Marketing Excellence Bayer | Consumer Health NA and renowned parenting influencer La Guardia Cross. Our session will get in to how influencers balance being a source of perspective for people without overpromising their qualifications and will unravel the intricate interplay between trust, cultural shifts, and the future trajectory of health and well-being brands. Add it to your SXSW schedule👇 #SXSW #TrustShift #BrandTrust #HealthWellness #InfluencerResponsibility #MarketingInnovation #DigitalInnovation

Healthcare evolves and innovates rapidly, and it can be challenging to cut through the noise and find relevant signals that inform the right action.     Today, we're announcing the launch of IRIS, the first insights-as-a-service platform designed to help industry leaders act with clarity and confidence when transformative #healthcare market events emerge — like we're seeing right now with GLP-1 agonists and obesity treatment.     Fueled by the analysis of billions of data points using our proprietary AI, IRIS offers a live dashboard and timely market-view reports to help leaders understand and navigate the rapidly evolving obesity and GLP-1 landscape.      Our first report dives deeper into the unprecedented impact of new "GLP-1 influencers" with online behaviors and monetization strategies that resemble beauty and fashion influencers more than the traditional healthcare social figures.     Learn how we're providing our clients and the healthcare industry with insights into what's happening now and the forces that could shape what's coming next: https://bit.ly/3wp8D0d

As we all monitor, fascinate, explore and wonder this new class of obesity drugs, GLP-1s, check our our first report about social influencers in that space as well as our new AI generated dashboard - IRIS. Fueled by the analysis of billions of data points using our proprietary AI, IRIS offers a live dashboard and timely market-view reports to help leaders understand and navigate the rapidly evolving obesity and GLP-1 landscape. @realchemistry